EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 4.0

Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling

Dandan Zhong, Jingshuo Chen, Ranran Qiao, Chang Song, Chang Hao, Yingying Zou, Mi Bai, Wen Su, Baoxue Yang, Dong Sun, Zhanjun Jia, Ying Sun

Cell Reports · 2024

DOI: 10.1016/j.celrep.2024.114075 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Cell Reports, 2024. Verfasst von Dandan Zhong und 11 weiteren Autor:innen. Beteiligte Einrichtung: Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China. Hauptthemen laut MEDLINE: Diabetic Nephropathies, Lipid Metabolism, Nuclear Receptor Subfamily 1, Group D, Member 1, Podocytes. Die Arbeit wurde bisher 13-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Xuzhou Science and Technology Program, National Natural Science Foundation of China.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Kein Abstract verfügbar.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetic NephropathiesLipid MetabolismNuclear Receptor Subfamily 1, Group D, Member 1PodocytesProstaglandin-E SynthasesSignal TransductionAnimalsHumansMaleMiceFatty Acid-Binding ProteinsFibrosisKidneyMice, Inbred C57BLMice, Knockout

Stichwörter der Autor:innen

CP: MetabolismCP: Molecular biologyFABP5Rev-Erbαdiabetic kidney diseaselipid accumulationmPGES-2

Substanzen

Fatty Acid-Binding ProteinsNr1d1 protein, mouseNuclear Receptor Subfamily 1, Group D, Member 1Prostaglandin-E SynthasesPtges protein, mousePtges2 protein, mouse

Autor:innen und Institutionen

  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China.
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China; Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University,…
  • Jiangsu Key Laboratory of New Drug Research and Clinical Pharmacy, Xuzhou Medical University, Xuzhou, Jiangsu 221004, P.R. China; Public Experimental Research Center of Xuzhou Medical University, Xuzhou Medical Universi…
  • Nanjing Key Laboratory of Pediatrics, Children's Hospital of Nanjing Medical University, Nanjing, Jiangsu 210008, P.R. China.
  • Department of Pathophysiology, Shenzhen University, Shenzhen 518060, China; Shenzhen University Health Science Center, Shenzhen University, Shenzhen 518060, China.
  • State Key Laboratory of Natural and Biomimetic Drugs, Department of Pharmacology, School of Basic Medical Sciences, Peking University, Beijing, China; State Key Laboratory of Vascular Homeostasis and Remodeling, Departm…

Förderung

  • Xuzhou Science and Technology Program
  • National Natural Science Foundation of China

Zitieren

APA

Zhong, D., Chen, J., Qiao, R., Song, C., Hao, C., Zou, Y., Bai, M., Su, W., Yang, B., Sun, D., Jia, Z., & Sun, Y. (2024). Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling. Cell Reports. https://doi.org/10.1016/j.celrep.2024.114075

Vancouver

Zhong D, Chen J, Qiao R, Song C, Hao C, Zou Y, et al. Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling. Cell Reports. 2024. doi:10.1016/j.celrep.2024.114075

BibTeX
@article{Zhong2024,
  author = {Zhong, Dandan and Chen, Jingshuo and Qiao, Ranran and Song, Chang and Hao, Chang and Zou, Yingying and Bai, Mi and Su, Wen and Yang, Baoxue and Sun, Dong and Jia, Zhanjun and Sun, Ying},
  title = {Genetic or pharmacologic blockade of mPGES-2 attenuates renal lipotoxicity and diabetic kidney disease by targeting Rev-Erbα/FABP5 signaling},
  journal = {Cell Reports},
  year = {2024},
  doi = {10.1016/j.celrep.2024.114075}
}
Kostenlos starten →